α-glucosidase inhibitory activities of myricetin in animal models of diabetes mellitus

The α-glucosidase inhibitory activity of myricetin in vivo was investigated. Streptozotocininduced diabetic rats were administered a starch solution (1 g/kg) with and without myricetin (100 mg/kg) or acarbose (40 mg/kg) after an overnight fast. Myricetin and acarbose alleviated postprandial hypergly...

Full description

Saved in:
Bibliographic Details
Published inFood science and biotechnology Vol. 24; no. 5; pp. 1897 - 1900
Main Authors Kang, Soo-Jeong, Park, Jung-Han Yoon, Choi, Ha-Neul, Kim, Jung-In
Format Journal Article
LanguageEnglish
Published Seoul The Korean Society of Food Science and Technology 01.10.2015
한국식품과학회
Subjects
Online AccessGet full text
ISSN1226-7708
2092-6456
DOI10.1007/s10068-015-0249-y

Cover

More Information
Summary:The α-glucosidase inhibitory activity of myricetin in vivo was investigated. Streptozotocininduced diabetic rats were administered a starch solution (1 g/kg) with and without myricetin (100 mg/kg) or acarbose (40 mg/kg) after an overnight fast. Myricetin and acarbose alleviated postprandial hyperglycemia conditions, compared with untreated rats. Consumption of 0.08% myricetin or 0.03% acarbose in the diet for 7 weeks significantly ( p <0.05) reduced the serum fasting glucose, blood glycated hemoglobin, and maltase activities of the small intestine in db/db mice, compared with controls. Myricetin can be beneficial for control of hyperglycemia in diabetes mellitus partly via inhibition of the a-glucosidase activity.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
G704-000139.2015.24.5.038
ISSN:1226-7708
2092-6456
DOI:10.1007/s10068-015-0249-y